Results 301 to 310 of about 540,096 (367)
The PBTN targets GRP78 and, upon X‐ray irradiation, generates ONOO− to induce immunogenic cell death, thereby activating CD8+ T cells and establishing a systemic antitumor immune response. ABSTRACT Nitric oxide (NO) treated radioresistant tumors by relieving hypoxia and blocking DNA repair, but its nonselective toxicity has precluded therapeutic use ...
Wanze Zhang +10 more
wiley +1 more source
A Bioinspired Approach to Next-Generation Vaccines in Solid Tumors with Engineered Cell Membranes. [PDF]
Zhang W, Chen M, Huang X.
europepmc +1 more source
PRC2.1(PCL2)‐coordinated H3K27me3‐enriched PNH establishes a spatial scaffold crucial for nucleolar integrity. As a crucial coordinator, PCL2 links PRC2.1 to chromatin organization and NPM1 assembly. This network‐based model reveals how chromatin modifications and nucleolar components cooperatively maintain nucleolar architecture, revealing novel ...
Lina Zhu +12 more
wiley +1 more source
Adapter-based allogeneic CAR T cells to overcome antigen escape in solid tumors. [PDF]
Pham PQ, Sodji QH.
europepmc +1 more source
Fluorescent BODIPY‐conjugated thiosemicarbazone ligands and their Ga(III), In(III), and Fe(III) complexes, inspired by Triapine, are developed as theranostic agents. Multiphoton FLIM and confocal microscopy in cancer cells and zebrafish reveal real‐time uptake, mitochondrial localisation, and whilst spectroscopic assays indicated preserved complex ...
Megan J. Green +15 more
wiley +1 more source
Efficacy and safety of tocilizumab for neoplastic fever in patients with advanced solid tumors: a multicenter retrospective study. [PDF]
Yan Y +12 more
europepmc +1 more source
Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies. [PDF]
Chen Y +9 more
europepmc +1 more source
CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead. [PDF]
Al Shaer NSH +6 more
europepmc +1 more source
Obstacles and improvement strategies for CAR-T cell therapy in solid tumors. [PDF]
Luo Z +9 more
europepmc +1 more source
Tumor-microenvironment-modulating microspheres to augment tumor-infiltrating lymphocyte therapy against solid tumors. [PDF]
Li M +13 more
europepmc +1 more source

